Back to Search
Start Over
Propranolol and breast cancer-a work in progress.
- Source :
-
Ecancermedicalscience [Ecancermedicalscience] 2018 Jun 18; Vol. 12, pp. ed82. Date of Electronic Publication: 2018 Jun 18 (Print Publication: 2018). - Publication Year :
- 2018
-
Abstract
- The non-selective beta-blocker propranolol is a leading candidate for repurposing as a novel anti-cancer agent. Emerging evidence, including human data, suggests that there are multiple mechanisms of action particularly relevant to breast cancer. This editorial reviews a number of recent studies that show it has anti-metastatic activity that warrants clinical investigation, including investigation as a potential perioperative therapy in breast cancer.
Details
- Language :
- English
- ISSN :
- 1754-6605
- Volume :
- 12
- Database :
- MEDLINE
- Journal :
- Ecancermedicalscience
- Publication Type :
- Editorial & Opinion
- Accession number :
- 30034523
- Full Text :
- https://doi.org/10.3332/ecancer.2018.ed82